Should investors spend more time considering the upside risks?
New cause of COVID-19 blood clots identified
Excessive alcohol consumption during the COVID-19 pandemic
Covid-19 roundup: Russian biotech seeks permission to produce remdesivir generic; Why did BARDA fund plasma company part-owned by Rick Santorum?
Study provides clues on curbing the aggressive nature of coronavirus
Man with flu-COVID infection found in the US – but he's not the first
New diagnostic test rapidly identifies bugs responsible for pneumonia
Regeneron, Lilly Setbacks Raise Questions on the Effectiveness of Antibodies in Severe COVID-19
AI’s infiltration of pharma: How COVID-19 accelerated change
Sanofi Inks Deal To Snap Up Kiadis For $359M; Street Bullish
J&J Strikes Covid-19 Vaccine Manufacturing Deal With Aspen
China’s Caixin PMI lifts Asian markets
Halloween Horror: Is it Covid-19 or Another Infection of the Night?
Krayden: What's At Stake On Tuesday
Humanigen Treats First Patient in Late-Stage COVID-19 Trial
AstraZeneca Sells Rights To Hypertension Drugs For $400M
US COVID-19 Cases Top 9 Million, Belgium Announces 6-Week National Lockdown: Live Updates
Week Ahead – Election Time!
Targeting Safe Income? Preferred Stocks Can Help
Regeneron Halts Covid-19 Trial For High-Flow Oxygen Patients; Shares Fall
New Covid Cases And Its Impacts On The Economy
Regeneron to stop enrolling very sick Covid-19 patients in antibody trials
SARS-CoV-2 might attack red marrow and block new erythrocytes formation
AstraZeneca sells off heart failure and hypertension drugs to Cheplapharm for $400M
Coronavirus stimulus checks: Pelosi presses White House for response, lists outstanding issues
NEJM: clinical trial indicates monoclonal antibody lowered hospitalizations and emergency visits
Covid-19 roundup: Flush with $486M contract, AstraZeneca signs Lonza up to manufacture antibodies; BioNTech's Ugur Sahin expects vaccine data 'in a fortnight'
Eli Lilly Nabs $312.5M US Army Contract For Covid-19 Treatment
Two more biotechs price IPOs, bringing total raise to record heights
Ipsen’s UK & Ireland MD on adapting business to COVID-19